Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Klava Innovationklava-innovation.comKLAVA Innovation developed Quitoxil®, a Class I digital therapeutic medical device for smoking cessation based on cognitive behavioral therapy. The product is available by prescription in French pharmacies and has shown a 51% reduction in tobacco consumption among users in a non-protocol study.
Parse Score
